These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24393340)

  • 1. The impact of regional co-payment and national reimbursement criteria on statins use in Italy: an interrupted time-series analysis.
    Damiani G; Federico B; Anselmi A; Bianchi CB; Silvestrini G; Iodice L; Navarra P; Da Cas R; Raschetti R; Ricciardi W
    BMC Health Serv Res; 2014 Jan; 14():6. PubMed ID: 24393340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy.
    Damiani G; Federico B; Silvestrini G; Bianchi CB; Anselmi A; Iodice L; Ronconi A; Navarra P; Da Cas R; Raschetti R; Ricciardi W
    Eur J Clin Pharmacol; 2013 Apr; 69(4):957-63. PubMed ID: 23090700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
    Fuksa L; Vocelka M; Vytrisalova M
    Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
    McRae I; van Gool K; Hall J; Yen L
    Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy implications of rationalization of statin use in Lithuania.
    Kadusevicius E; Jankauskiene D; Paulauskaite I; Slapikas R
    Int J Technol Assess Health Care; 2009 Jul; 25(3):419-24. PubMed ID: 19619363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of reimbursement changes on statin use among patients with diabetes in Austria.
    Winkelmayer WC; Asslaber M; Bucsics A; Burkhardt T; Schautzer A; Wieninger P; Pogantsch M; Brookhart MA;
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):89-94. PubMed ID: 20213375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors.
    Hsu CY; Chen WJ; Chen HM; Tsai HY; Hsiao FY
    J Clin Pharm Ther; 2021 Apr; 46(2):415-423. PubMed ID: 33180353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
    Bennie M; Godman B; Bishop I; Campbell S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG; Huether JR; Handke LJ; Williams CE
    J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH; Kazerooni R; Bounthavong M
    J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.
    Liao KH; Ko BS; Chen LK; Hsiao FY
    Clin Transl Sci; 2020 Nov; 13(6):1288-1297. PubMed ID: 32583962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
    McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
    Fraeyman J; Verbelen M; Hens N; Van Hal G; De Loof H; Beutels P
    Appl Health Econ Health Policy; 2013 Oct; 11(5):543-52. PubMed ID: 24062144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision.
    Trifirò G; Alacqua M; Corrao S; Moretti S; Tari DU; Galdo M; ; Caputi AP; Arcoraci V
    Eur J Clin Pharmacol; 2008 Jun; 64(6):619-25. PubMed ID: 18213473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.
    Thai LP; Moss JR; Godman B; Vitry AI
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):419-33. PubMed ID: 26707482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Trends in Statin Use in Lithuania from 2010 to 2021.
    Makarevičius G; Rinkūnienė E; Badarienė J
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676661
    [No Abstract]   [Full Text] [Related]  

  • 20. Zero copayment for generic statins could save billions.
    Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.